Maze Therapeutics Balance Sheet (2024-2025) | MAZE

Balance Sheet Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Accumulated Depreciation (Quarter) 16.87M19.21M
Assets
Current Assets
Cash & Equivalents (Quarter) 30.02M175.06M149.61M196.81M294.40M264.50M316.77M189.25M
Receivables - Other (Quarter) 0.70M1.50M
Prepaid Assets (Quarter) 4.86M5.33M6.61M7.37M7.80M
Current Assets (Quarter) 201.67M299.71M271.15M391.30M349.72M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 6.67M6.31M6.01M5.54M5.04M
Long-Term Investments (Quarter) 18.11M
Other Non-Current Assets (Quarter) 7.87M1.09M3.57M1.09M1.10M
Non-Current Assets (Quarter) 38.87M33.13M32.37M30.76M47.41M
Assets (Quarter) 240.54M332.84M303.52M422.06M397.13M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.94M2.40M3.67M2.92M1.79M
Payables (Quarter) 1.94M2.40M3.67M2.92M1.79M
Accumulated Expenses (Quarter) 8.08M11.54M11.52M8.19M15.97M
Other Accumulated Expenses (Quarter) 2.93M4.95M0.06M4.30M
Current Leases (Quarter) 4.63M4.67M4.72M4.76M4.80M
Total Current Liabilities (Quarter) 20.67M18.62M19.90M22.11M22.56M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 383.90M383.90M383.90M508.09M
Operating Leases (Quarter) 22.00M21.15M20.29M19.42M18.50M
Other Non-Current Liabilities (Quarter) 0.97M1.01M1.09M1.09M1.09M
Total Non-Current Liabilities (Quarter) 42.67M39.77M40.19M41.53M41.07M
Total Liabilities (Quarter) 403.66M262.37M284.53M43.64M40.77M41.28M42.62M42.16M
Shareholder's Equity
Common Equity (Quarter) -403.66M-262.37M-284.53M-311.18M292.07M262.24M379.44M354.97M
Shareholder's Equity (Quarter) -403.66M-262.37M-284.53M-311.18M292.07M262.24M379.44M354.97M
Liabilities and Shareholders Equity (Quarter) 240.54M332.84M303.52M422.06M397.13M
Retained Earnings (Quarter) -358.43M-391.21M-424.89M-454.98M-489.50M
Treasury Shares (Quarter) 0.01M0.01M0.59M0.01M
Shares Outstanding (Quarter) 2.42M2.42M2.44M2.45M43.80M43.85M48.08M49.34M